Zosano Pharma Corp (ZSAN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

34790 ARDENTECH COURT FREMONT, CA 94555

Zosano Pharma Corp provides biopharmaceutical products and services. The Company specializes in biopharmaceuticals, peptides, small water soluble molecules, monoclonal antibodies, and vaccines fort he treatment of severe osteoporosis.

Data as of 2021-05-08 11:36:27 -0400
Market Cap89.172 Million Shares Outstanding106.728 Million Avg 30-day Volume2.004 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.58 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.4385 52-week High/Low3.06 / 0.3275 Next Earnings Date2021-05-13 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ZSAN instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 35 43 -18.6% 10 (0.6%) 13 (0.81%) -23.08%
13F shares: 10.916 Million 13.058 Million -16.41% 5.445 Million 7.148 Million -23.82%
% Ownership 10.6949 13.656 -21.68% 5.3349 7.4752 -28.63%
New Positions: 6 14 -57.14% 1 4 -75.0%
Increased Positions 8 14 -42.86% 2 3 -33.33%
Closed Positions 14 4 250.0% 4 1 300.0%
Reduced Positions 8 1 700.0% 2
Total Calls 15.922 Thousand 15.922 Thousand 0.0% 15.922 Thousand 15.922 Thousand 0.0%
Total Puts
PUT/CALL Ratio 0.0 0.0 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ZSAN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZSAN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KELLERMAN DONALD J VP, CLINICAL DEV & MED AFFAIRS

  • Officer
117,046 2021-03-30 3

LEWIS HAYLEY SEE REMARKS

  • Officer
116,488 2021-03-30 3

LO STEVEN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
843,750 2021-03-30 4

MATTHEWS CHRISTINE CHIEF FINANCIAL OFFICER

  • Officer
262,500 2021-03-30 3

XANTHOPOULOS KLEANTHIS G

8,596 2020-06-25 2

HAGAN JOSEPH P

7,500 2020-06-25 2

WALKER JOHN PETER

116,511 2020-06-25 2

GREATHOUSE KENNETH

17,500 2020-06-25 2

ELMS STEVE

2,725,766 2020-06-25 2

GRAIS LINDA S

7,500 2020-06-25 3

AISLING CAPITAL IV, LP

AISLING CAPITAL PARTNERS IV, LP

AISLING CAPITAL PARTNERS IV LLC

ELMS STEVE

SCHIFF ANDREW N

  • 10% Owner
2,718,226 2019-12-02 0

KITCHENER GREGORY DAVID CHIEF FINANCIAL OFFICER

  • Officer
0 2019-06-11 0

WILSON TROY EDWARD

  • Director
0 2019-01-02 0

AISLING CAPITAL IV, LP

ELMS STEVE

SCHIFF ANDREW N

  • 10% Owner
1,600,000 2018-03-29 2

AMZAK CAPITAL MANAGEMENT, LLC

KAZMA MICHAEL D

KAZMA GERALD J

  • 10% Owner
No longer subject to file 2018-02-26 0

ERBEZ GEORGIA CFO AND CHIEF BUSINESS OFFICER

  • Officer
115,750 2017-05-25 0

TSO WINNIE WING-KEI CHIEF FINANCIAL OFFICER

  • Officer
0 2017-04-10 0

ALATARIS KONSTANTINOS PRESIDENT, CEO

  • Officer
  • Director
254,778 2017-03-20 0

BARRETT M JAMES

  • 10% Owner
No longer subject to file 2017-02-13 0

NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

NEA PARTNERS 12, LIMITED PARTNERSHIP

NEA 12 GP, LLC

BARRIS PETER J

BASKETT FOREST

KERINS PATRICK J

SANDELL SCOTT D

  • 10% Owner
No longer subject to file 2017-02-13 0

NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

NEA PARTNERS 12, LIMITED PARTNERSHIP

NEA 12 GP, LLC

BARRIS PETER J

BASKETT FOREST

KERINS PATRICK J

KOLLURI KRISHNA KITTU

SANDELL SCOTT D

  • 10% Owner
2,052,805 2016-09-16 0

SCHARIN ERIC VP, ENGINEERING & OPERATIONS

  • Officer
0 2016-06-30 0

PERI LAXMI SR. VICE PRESIDENT, OPERATIONS

  • Officer
0 2015-12-15 0

NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

NEA PARTNERS 12, LIMITED PARTNERSHIP

NEA 12 GP, LLC

BARRIS PETER J

BASKETT FOREST

DRANT RYAN D

KERINS PATRICK J

KOLLURI KRISHNA KITTU

SANDELL SCOTT D

  • 10% Owner
2,158,539 2015-01-30 0

BIOMED REALTY TRUST INC

BIOMED REALTY L P

  • 10% Owner
2,442,429 2015-01-30 0

LILLY ELI & CO

  • 10% Owner
1,363,636 2015-01-30 0

DADDONA PETER E. CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
318,787 2015-01-26 0

LAMBA VIKRAM PRESIDENT, CEO

  • Officer
  • Director
  • 10% Owner
631,250 2015-01-26 0

OZA NANDAN CHIEF OPERATING OFFICER

  • Officer
0 2015-01-26 0

STEEL BRUCE D.

  • Director
0 2015-01-26 0

STRANGE ALEXANDER RAMSAY VP, STRATEGY & CORP. DEVELOP.

  • Officer
0 2015-01-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LEWIS HAYLEY - Officer SEE REMARKS

2021-04-01 21:33:02 -0400 2021-03-30 A 65,000 a 65,000 direct

MATTHEWS CHRISTINE - Officer CHIEF FINANCIAL OFFICER

2021-04-01 21:30:40 -0400 2021-03-30 A 81,250 a 100,000 direct 2.4194 -10.4839 2.4194 2 -10.4839 6

KELLERMAN DONALD J - Officer VP, CLINICAL DEV & MED AFFAIRS

2021-04-01 21:31:37 -0400 2021-03-30 A 65,000 a 65,000 direct

LEWIS HAYLEY - Officer SEE REMARKS

2021-04-01 21:33:02 -0400 2021-03-30 A 32,500 a 51,488 direct 2.4194 -10.4839 2.4194 2 -10.4839 6

LO STEVEN - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-01 21:33:55 -0400 2021-03-30 A 465,000 a 465,000 direct

KELLERMAN DONALD J - Officer VP, CLINICAL DEV & MED AFFAIRS

2021-04-01 21:31:37 -0400 2021-03-30 A 32,500 a 52,046 direct 2.4194 -10.4839 2.4194 2 -10.4839 6

MATTHEWS CHRISTINE - Officer CHIEF FINANCIAL OFFICER

2021-04-01 21:30:40 -0400 2021-03-30 A 162,500 a 162,500 direct

LO STEVEN - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-01 21:33:55 -0400 2021-03-30 A 232,500 a 378,750 direct 2.4194 -10.4839 2.4194 2 -10.4839 6

LO STEVEN - Director - Officer CHIEF EXECUTIVE OFFICER

2021-03-19 18:13:08 -0400 2021-03-18 A 450,000 a 450,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ZOSANO PHARMA CORP ZSAN 2021-05-11 22:15:03 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 21:45:03 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 21:15:03 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 20:45:03 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 20:15:03 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 19:45:03 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 19:15:02 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 18:45:02 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 18:15:03 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 17:45:03 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 17:15:04 UTC -6.5409 6.5909 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 16:45:04 UTC -7.0167 7.0667 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 16:15:04 UTC -7.0167 7.0667 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 15:45:03 UTC -7.0167 7.0667 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 15:15:03 UTC -7.0167 7.0667 1100000
ZOSANO PHARMA CORP ZSAN 2021-05-11 14:45:03 UTC -7.0167 7.0667 1000000
ZOSANO PHARMA CORP ZSAN 2021-05-11 14:15:03 UTC -7.0167 7.0667 1500000
ZOSANO PHARMA CORP ZSAN 2021-05-11 13:45:04 UTC -7.0167 7.0667 1500000
ZOSANO PHARMA CORP ZSAN 2021-05-11 13:15:04 UTC -7.0167 7.0667 1500000
ZOSANO PHARMA CORP ZSAN 2021-05-11 12:45:03 UTC -7.0167 7.0667 1500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ZSAN -29996.0 shares, $-37195.04 2021-03-31 N-PORT

Elevate your investments